Molecular Analysis Expands the Spectrum of Phenotypes Associated with GLI3 Mutations
Tarih
2010Yazar
Gal, Moran
Kidd, Alexa M. J.
Kimonis, Virginia
Lin, Angela E.
Lynch, Sally Ann
Maisenbacher, Melissa
Mansour, Sahar
McGaughran, Julie
Mehta, Lakshmi
Murphy, Helen
Raygada, Margarita
Robin, Nathaniel H.
Rope, Alan F.
Rosenbaum, Kenneth N.
Schaefer, G. Bradley
Shealy, Amy
Smith, Wendy
Soller, Maria
Sommer, Annmarie
Stalker, Heather J.
Steiner, Bernhard
Stephan, Mark J.
Tilstra, David
Tomkins, Susan
Trapane, Pamela
Tsai, Anne Chun-Hui
Van Allen, Margot I.
Vasudevan, Pradeep C.
Zabel, Bernhard
Zunich, Janice
Black, Graeme C. M.
Biesecker, Leslie G.
Kayserili, Hulya
Johnston, Jennifer J.
Sapp, Julie C.
Turner, Joyce T.
Amor, David
Aftimos, Salim
Aleck, Kyrieckos A.
Bocian, Maureen
Bodurtha, Joann N.
Cox, Gerald F.
Curry, Cynthia J.
Day, Ruth
Donnai, Dian
Field, Michael
Fujiwara, Ikuma
Gabbett, Michael
Graham, John M.
Hedera, Peter
Hennekam, Raoul C. M.
Hersh, Joseph H.
Hopkin, Robert J.
Üst veri
Tüm öğe kaydını gösterÖzet
A range of phenotypes including Greig cephalopolysyndactyly and Pallister-Hall syndromes (GCPS, PHS) are caused by pathogenic mutation of the GLI3 gene. To characterize the clinical variability of GLI3 mutations, we present a subset of a cohort of 174 probands referred for GLI3 analysis. Eighty-one probands with typical GCPS or PHS were previously reported, and we report the remaining 93 probands here. This includes 19 probands (12 mutations) who fulfilled clinical criteria for GCPS or PHS, 48 probands (16 mutations) with features of GCPS or PHS but who did not meet the clinical criteria (sub-GCPS and sub-PHS), 21 probands (6 mutations) with features of PHS or GCPS and oral-facial- digital syndrome, and 5 probands (1 mutation) with nonsyndromic polydactyly. These data support previously identified genotype-phenotype correlations and demonstrate a more variable degree of severity than previously recognized. The finding of GLI3 mutations in patients with features of oral-facial-digital syndrome supports the observation that GLI3 interacts with cilia. We conclude that the phenotypic spectrum of GLI3 mutations is broader than that encompassed by the clinical diagnostic criteria, but the genotype-phenotype correlation persists. Individuals with features of either GCPS or PHS should be screened for mutations in GLI3 even if they do not fulfill clinical criteria. Hum Mutat 31:1142-1154, 2010. (C) 2010 Wiley-Liss, Inc.
Koleksiyonlar
- Makale [92796]